Quince Therapeutics Stock Pauses After Volatile Biotech Moves
Quince Therapeutics shares didn't move Monday as markets shut for Memorial Day. Investors were left with several updates from the small-cap biotech last week: a pipeline buy, plans for a sizable private funding, and a filing that lifted a short-term listing risk. Nasdaq will stay closed on Memorial Day again in 2026, which falls on May 25, according to its holiday calendar. Quince Therapeutics shares finished Friday at $1.10, rising 2.8% for the day on roughly 1.23 million shares traded, according to the company’s investor-relations page. The stock still posted a 4.3% drop for the week after closing at $1.15 the previous Friday, weighed by a choppy Monday after its Orphai Therapeutics news.
